The impact of pausing the Oxford-AstraZeneca COVID-19 vaccine on uptake in Europe: a difference-in-differences analysis

Vageesh Jain, Paula Lorgelly
doi: https://doi.org/10.1101/2021.08.30.21262821

Article usage

Article usage: August 2021 to December 2024

AbstractFullPdf
Aug 2021355038
Sep 2021187785160
Oct 20211181758
Nov 202193229
Dec 202161916
Jan 20223466
Feb 202268410
Mar 202258512
Apr 20225819
May 20224519
Jun 20223219
Jul 20223526
Aug 202231612
Sep 202233311
Oct 20222808
Nov 20222815
Dec 20221616
Jan 20232207
Feb 20231624
Mar 20231213
Apr 20232813
May 20231617
Jun 2023642
Jul 2023923
Aug 202317135
Sep 20231845
Oct 20231001
Nov 20231023
Dec 20231302
Jan 2024813
Feb 20241637
Mar 2024831
Apr 2024441
May 2024322
Jun 20241743
Jul 2024905
Aug 20241936
Sep 202414113
Oct 20241374
Nov 20241414
Dec 2024506
Back to top
Posted August 31, 2021.
Download PDF

Supplementary Material

Data/Code
Email
The impact of pausing the Oxford-AstraZeneca COVID-19 vaccine on uptake in Europe: a difference-in-differences analysis
Vageesh Jain, Paula Lorgelly
medRxiv 2021.08.30.21262821; doi: https://doi.org/10.1101/2021.08.30.21262821
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area